ARTICLES BY THIS AUTHOR
- 8/31/2011
Drug News: September 2011
Benlysta: new IV immunosuppressant for SLE; Brilinta: new antiplatelet agent for prevention of CV events after ACS. - 8/31/2011
Ontario adds more paid pharmacy services
Pharmacists can now claim reimbursement for smoking cessation counselling and pharmaceutical opinions. - 8/31/2011
Ontario CMPA fees to drop 54% next year
Decrease due to pressure from Ontario government but doctors call it ‘cash grab’ that will undermine reserve - 8/31/2011
Adverse Reactions: Long-term safety of PPIs
Two recent publications highlight the long-term safety of these medications, specifically concerning the development of hypomagnesemia and the increased risk of bone fractures. - 8/31/2011
Clinical Notes: PPI efficacy and safety in children with GERD
PPIs not effective in reducing gastroesophageal reflux disease symptoms in infants, study finds. - 8/31/2011
Ethics and Issues: Asking about adherence
What is the best way to ask patients about adherence? - 8/31/2011
Alliance against teen drug abuse seeks pharmacists’ help
Partnership for Drug Free Canada launches multi-media campaign. - 8/31/2011
References: Managing chemotherapy side effects
Cancer care in the community: the drugstore's role. - 8/31/2011
SickKids wins gold for innovative business model
The commitment to innovation of The Hospital for Sick Children (SickKids) in Toronto has been recognized by the Institute of Public Administration of Canada with a Gold Award in Innovative Management. - 8/31/2011
Staxyn: new rapid-dissolving vardenafil tablet for erectile dysfunction
Drug is the first phosphodiesterase type 5 inhibitor marketed in an orally disintegrating tablet dosage form.